NAFDAC Gives Nigerian Food Companies 18 Months to Cut Trans Fats

NAFDAC Gives Nigerian Food Companies 18 Months to Cut Trans Fats

The National Agency for Food and Drug Administration and Control has set an 18-month grace period, effectively giving food companies until early 2026 before facing full enforcement of regulations to eliminate industrially produced Trans-Fatty Acids (TFA). The initiative, launched as a comprehensive strategy and roadmap for TFA regulation, moves Nigeria from simply having the policy to enforcing its world-class standard: a regulatory limit of no more than two grams of industrially produced trans fat per 100 grams of total fat or oil. The Director-General of NAFDAC, Professor Mojisola Adeyeye, emphasised that the roadmap moves the country beyond policy creation to aggressive enforcement and implementation. This was contained in the NAFDAC DG’s keynote speech posted on the agency’s official X (formerly Twitter) on Friday. Adeyeye stressed the moral imperative of the Agency’s mission. “The removal of industrially produced trans fats from the food chain is not only a technical achievement, but a moral imperative. “Eliminating industrially produced trans fats is possible, achievable, necessary, and urgent,” Adeyeye stated, calling for national collaboration. The moratorium period is designed to allow manufacturers to exhaust existing stock with outdated labels and reformulate their products to comply with the legal limit. NAFDAC’s action targets a dangerous dietary risk factor strongly linked to cardiovascular disease, stroke, and premature death globally. Adeyeye emphasised the significance of the move beyond technical compliance, noting, “The removal of industrially produced trans fats from the food chain is not only a technical achievement, but a moral imperative.” This aggressive step builds upon Nigeria’s existing reputation; the country was recognised by the World Health Organisation in 2023 for adopting best-practice TFA elimination policies. The new roadmap is key to securing WHO validation of Nigeria’s full TFA elimination programme, establishing the nation as a regional leader in public health interventions.

Onitsha Trader Sues NAFDAC, Demands N15m Over Shop Invasion

  A female clothing dealer at Ogbo-Ogwu Bridgehead Market in Onitsha, Anambra State, Sophie Okoye, has filed a legal suit against the National Agency for Food and Drug Administration and Control and its Director-General, at the Federal High Court, Awka. Okoye claimed that her store, which deals exclusively in clothing, watches, and fashion accessories, with no connection whatsoever to pharmaceutical trade, nevertheless, was targeted in a sweeping enforcement allegedly executed by a joint task force acting under NAFDAC’s authority. The aggrieved trader filed the suit following the expiration of the statutory period outlined in the pre-action notice served on NAFDAC. According to the court documents obtained by our correspondent, on Friday, the matter is between Sophie Eberechukwu Okoye as plaintiff and NAFDAC and its DG as defendants in the Suit No. FHC/AWK/CS/162/25, filed at the Federal High Court, Awka. In the suit, the aggrieved trader is suing the regulatory agency for unlawfully breaking into her shop and/or carting away her goods valued at over N15 million, saying that her items are not affiliated whatsoever with drugs, food, or chemicals. Among other declarations by the plaintiff include: “That the defendants have no power in the administration, management, and control of food and drugs to oppressively, unlawfully and unconstitutionally break into the shop of the plaintiff looted/carted away the plaintiff’s items that are not affiliated whatsoever with drugs, food or chemicals. “That the defendant’s unlawful seizure and/or carting away of the plaintiff’s goods as listed with their value and quantity, is not only oppressive, unreasonable, but also unlawful, illegal, and unconstitutional. “An order of the honourable court directing the defendants to pay to the plaintiff the sum of N15,746.00 being the monetary value of the items carted away from the plaintiff’s shop by the defendants.” Speaking on the development, the counsel for the plaintiff, Ifeanyi Ejiofor, said the suit was filed following the expiration of the statutory period outlined in the pre-action notice served on NAFDAC. Ejiofor stated that once this mandatory notice period had elapsed, legal action against the regulatory agency would be promptly initiated. He said, “In every just and democratic society, the rule of law is sacrosanct. “No agency, regardless of its mandate, has the right to operate beyond the legal boundaries that define its existence. “The recent developments at Ogbo-Ogwu Bridgehead Market in Onitsha, Anambra State, are a shameful testament to the dangers of institutional overreach and the betrayal of fundamental legal principles. “The now widely circulated footage of Sophie Okoye, a young trader reduced to tears after her shop was unlawfully broken into and looted, has shocked the conscience of the nation. “Her store, which deals exclusively in clothing, watches, and fashion accessories, has no connection whatsoever to the pharmaceutical trade. “Nevertheless, it was targeted in a sweeping operation allegedly executed by a joint task force acting under NAFDAC’s authority.” He, however, called on both the Federal Government and the Government of Anambra State to immediately constitute an independent investigative panel, which must audit the entire operation, identify all those responsible, and ensure they are brought to justice. “While we unequivocally support NAFDAC’s statutory mandate to rid markets of counterfeit and substandard drugs, no mission, however noble, can justify the trampling of innocent citizens’ rights or the destruction of lawful businesses.” Ejiofor stated that justice must never become collateral damage. He vowed that neither he nor his client would be silenced or back down. “Justice must be done and must be seen to be done,” Ejiofor added. Punch  

Combiart Dispersible Tablet: NAFDAC Warns Nigerians Of Fake Anti-Malaria Drugs In Circulation

  NAFDAC, National Agency for Food and Drugs Administration and Control has raised an alert over the circulation of counterfeit Combiart Dispersible Tablet 20/120mg in Nigeria. NAFDAC disclosed this via a post on its X handle. According to the agency, the product is manufactured by Strides Arcolab Limited, based in India. “This product was discovered in the FCT and Rivers State during surveillance activities conducted by officers of the Post Marketing Surveillance Directorate of NAFDAC. “The laboratory report of the analysis carried out on the product revealed that it contained zero active pharmaceutical ingredients. The product was also observed to have two different date markings. The NAFDAC database of registered products confirmed that the product licence has expired, and the NAFDAC registration number on it is incorrect and does not belong to the product. “The Artemether and Lumefantrine combination belongs to a group of medicines known as antimalarials. It treats malaria, a red blood cell infection transmitted by mosquito bites. However, this medicine is not used to treat severe or complicated malaria,” NAFDAC stated. The agency warned that counterfeit medicines pose significant risks to health as they do not meet regulatory standards, meaning their safety, quality, and efficacy cannot be assured. It added that counterfeit medicines often fail to effectively treat conditions, leading to severe health consequences, including death. NAFDAC identified the product’s batch number as 7225119, with a NAFDAC registration number of A11-0299. It noted that the manufacturing dates on the product were June 2023 and February 2023, while the expiry dates were May 2026 and June 2026. The manufacturer’s name and address were listed as: Strides Arcolab Limited, 36/7, Suragajakkanahalli, Indlavadi Cross, Anekal Taluk, Bangalore (562 106), India. The agency directed all its zonal directors and state coordinators to conduct surveillance and remove counterfeit products from circulation. Importers, distributors, retailers, healthcare professionals, and caregivers were urged to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of counterfeit products. “All medical products must be obtained from authorized/licensed suppliers. The authenticity and physical condition of the products should be carefully checked,” NAFDAC advised. Healthcare professionals and consumers were also urged to report any suspicion of substandard or falsified medicines or medical devices to the nearest NAFDAC office. Reports can also be made via the NAFDAC hotline at 0800-162-3322 or by email at sf.alert@nafdac.gov.ng. Similarly, adverse events or side effects related to the use of medicines or devices should be reported through the NAFDAC e-reporting platform on its website, the Med-Safety app (available on Android and iOS), or via email at pharmacovigilance@nafdac.gov.ng. NAFDAC noted that the alert will also be uploaded to the World Health Organisation Global Surveillance and Monitoring System.

NAFDAC Workers Embark On Indefinite Strike

  The strike follows multiple meetings with NAFDAC management which failed to yield desired outcomes regarding critical issues affecting staff. Some of the issues include a review of the 2024 promotion examination results, the appointment of directors for public affairs/special duties, training institute, and reform of promotion examination content. Others are the creation of a psychology officer cadre by HOS circular, payment of all pending burial expenses, life insurance and repatriation allowance, and salary arrears for 2022 employees. In a statement, Ejor Michael, TUC secretary, said the workers had issued a 14-day ultimatum to the agency’s management in a communique dated September 20, 2024. The statement said another congress of NAFDAC staff was convened on October 4, following the expiration of the ultimatum. “After careful deliberation, Congress unanimously resolved to embark on an indefinite nationwide strike across all NAFDAC formations, commencing Monday, 7th October 2024,” the statement reads. “In view of the foregoing, you are hereby directed to down tools by withdrawing all your services in compliance with the strike action. We will not relent until all issues are satisfactorily addressed.”

NAFDAC Issues Warning To Nigerians About Fake Dettol Soap

  NAFDAC has alerted Nigeria to the sale of a fake soap labeled as “Dettol Health Fresh Soap” in the market. According to the alert on NAFDAC’s website on Thursday, the manufacturer of Dettol Antiseptic products confirmed that the soap is fake as it does not have any product by the name “Dettol Health Fresh Soap.” “The Marketing Authorisation Holder and manufacturer (Reckitt Benckiser Nigeria Limited) of Dettol Antiseptic products, received a consumer complaint regarding the above-mentioned product. The product was reported to have caused skin irritation to the complainant. “The MAH has confirmed that the product is fake as they do not have any product by the name “Dettol Health Fresh Soap”. Dettol Antiseptic products are widely used in Nigeria for household disinfection and personal hygiene to prevent illnesses from germs (bacterial infection),” it said. It added that details of the complaint product were not provided by the complainant except for the name of the product “Dettol Health Fresh Soap.” The agency noted that the illegal marketing of NAFDAC-regulated products or fake products poses a risk to people’s health, and since they do not comply with the regulatory provisions, the products’ safety, quality, and efficacy are not guaranteed. It said all NAFDAC zonal directors and state coordinators have been directed to carry out surveillance and mop up the fake product if found within the zones and states. “Importers, distributors, retailers, healthcare professionals, caregivers, and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the fake product. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked. “Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical products to the nearest NAFDAC office, NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng. “Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng”